| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1532-5415.2001.49173.X |
| P698 | PubMed publication ID | 11527474 |
| P2093 | author name string | Rosen CJ | |
| Kiel DP | |||
| Hennessey JV | |||
| Reinert SE | |||
| MacLean DB | |||
| Puhl J | |||
| Chromiak JA | |||
| Vandenburgh H | |||
| DellaVentura S | |||
| P2860 | cites work | Effects of human growth hormone in men over 60 years old | Q28288413 |
| The etiology and reversibility of muscle dysfunction in the aged | Q40864006 | ||
| Human growth hormone and human aging | Q40906146 | ||
| Growth hormone replacement in healthy older men improves body composition but not functional ability | Q43506669 | ||
| An objective measure of physical function of elderly outpatients. The Physical Performance Test. | Q45979149 | ||
| Human growth hormone treatment of hypophysectomized rats increases the proportion of type-1 fibres in skeletal muscle | Q46444621 | ||
| Lack of an association between insulin-like growth factor-I and body composition, muscle strength, physical performance or self-reported mobility among older persons with functional limitations | Q47817517 | ||
| Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults. | Q50936953 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 852-858 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | Journal of the American Geriatrics Society | Q6296094 |
| P1476 | title | Growth hormone administration and exercise effects on muscle fiber type and diameter in moderately frail older people | |
| P478 | volume | 49 |
| Q38445302 | A model for determining baseline morphometrics of skeletal myofibres |
| Q36816921 | Aging and the growth hormone/insulin like growth factor-I axis |
| Q35682938 | Anabolic hormones in aging women: effects of supplementation vs. physical activity |
| Q37409213 | Effects of Growth Hormone Administration on Muscle Strength in Men over 50 Years Old |
| Q36789451 | Effects of different exercise interventions on risk of falls, gait ability, and balance in physically frail older adults: a systematic review |
| Q33739028 | Effects of multi-domain interventions in (pre)frail elderly on frailty, functional, and cognitive status: a systematic review |
| Q37379541 | Growth hormone and sex steroid effects on serum glucose, insulin, and lipid concentrations in healthy older women and men. |
| Q35684580 | Growth hormone in anti-aging medicine: a critical review |
| Q27024785 | Growth hormone in the aging male |
| Q37396676 | Growth hormone, menopause and ageing: no definite evidence for 'rejuvenation' with growth hormone |
| Q46663978 | Hormone therapy and anti-aging: is there an indication? |
| Q45016999 | Hormone therapy in the aging male. Estrogen, DHEA, melatonin, somatotropin |
| Q37257924 | Modulation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults |
| Q37502104 | Multiple hormonal dysregulation as determinant of low physical performance and mobility in older persons. |
| Q98465004 | Optimizing Skeletal Muscle Anabolic Response to Resistance Training in Aging |
| Q24239854 | Progressive resistance strength training for improving physical function in older adults |
| Q24248722 | Progressive resistance strength training for physical disability in older people |
| Q36736100 | Regulation of muscle mass by growth hormone and IGF-I. |
| Q28579347 | Skeletal muscle IGF-binding protein-3 and -5 expressions are age, muscle, and load dependent |
| Q33680155 | Strength and endurance training prescription in healthy and frail elderly |
| Q35626696 | Systematic review of progressive resistance strength training in older adults |
| Q37212304 | Testosterone and growth hormone improve body composition and muscle performance in older men. |
| Q34974738 | The effectiveness of exercise interventions for the management of frailty: a systematic review |
| Q37958026 | The frailty syndrome: a comprehensive review |
| Q38729143 | Use of growth hormone, IGF-I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects. |
| Q37573464 | Validated treatments and therapeutics prospectives regarding pharmacological products for sarcopenia |
| Q84245432 | [Dermatoendocrinology. Skin aging] |
| Q84136142 | [Growth hormone therapy in adult patients: a review] |
| Q81803739 | [Growth hormone therapy in adults] |
Search more.